Established in 1929
Health City Sun
50¢
The
www.healthcitysun.com
November 13, 2020
New Mexico’s Legal & Financial Weekly
Vol. 10.100 No. 46
FORECLOSURE SALES: 0 PROBATE: 42 AUCTIONS: 9 NOTICE OF SUITS: 3 OTHER: 32 SPANISH NOTICES: 1
Novel Cell Therapy May Improve Heart Failure Symptoms
*Publish Legal Notices for Less!*
63¢ / line for first week 49¢ / line for additional weeks
T
he COVID-19 pandemic has left many people with serious medical conditions, such as heart failure, feeling fearful about coming into the hospital for treatment. A recent study showed a 40 percent drop in patients seeking medical care for serious heart attacks over the last few months. If left unaddressed, the condition may turn into heart failure, which may limit treatment options even further. Doctors are urging patients not to delay treatment. The good news is that clinical trials for heart disease are underway, studying cutting-edge treatments for heart failure that may be a good option for these patients. One such treatment being studied uses a patient’s own cells to promote healing of the heart after a heart attack that has progressed to heart failure. The CardiAMP cell therapy is designed for patients suffering from heart failure who feel tired and breathless despite taking regular medications, and who have had to limit their everyday activities as a result. Previously published studies of this type of cell therapy have shown meaningful and sustained improvements in quality of life and heart function for patients with few risks.
Prepaid copy provided by: Prime Time Publishing llc. 2020 Pete Hagerstrom, a 73-year-old from Colorado Springs who had a previous quadruple bypass to treat his heart failure, was the first patient in his state enrolled in the ongoing FDA-approved clinical study of the therapy. Participants who qualify for the study are randomly placed into a treatment group or a control group. While Mr. Hagerstrom will not know until the end of the study if he received the cell therapy, he feels better after participating in the trial. “Everything is easier. I can walk three miles in about 45 minutes, and it takes a lot less time to garden and shovel snow.”
The CardiAMP Heart Failure Trial will include up “Heart failure patients who continue to have to 260 patients at 40 medical centers nationwide. symptoms despite a course of optimal medications often seek a minimally invasive treatment as Unlike similar studies, this trial tests a patient’s an alternative to open heart surgery. We look bone marrow before treatment, in order to identify forward to studying the potential of this cell those patients who are most likely to benefit from therapy to improve heart function and quality of treatment. life,” said Dr. Natasha Altman, cardiologist and principal investigator of the CardiAMP Heart Failure Trial at UC Health University of Colorado Patients may be candidates for the CardiAMP Heart Failure Trial if they Hospital. have heart failure as a result of an earlier heart attack and have symptoms that are classified as New York Heart Association Class II or III. For the treatment, doctors extract cells from a patient’s own bone marrow, process them at the point of care and deliver them to the damaged area For more information about the CardiAMP Heart Failure trial, visit www. of the heart in a minimally invasive cardiac catheterization procedure. biocardia.com, www.clinicaltrials.gov/ct2/show/NCT02438306, or ask Researchers emphasize that the bone marrow cells do not turn into new your cardiologist. heart tissue cells; instead, they are designed to stimulate the body’s natural healing process in the heart. -(NewsUSA)
COVID-19 Elevating Concerns About Food Safety and Security
T
he latest fallout from the coronavirus pandemic? Food safety and Doubt it? “New food safety threats, like those posed by COVID-19, are security now rank among consumers’ top global concerns. constantly emerging through a combination of factors including global warming, increased globalization of trade, and changes in agriculture According to a new study from the Mars Global Food Safety Center, 73 practices and food production,” said David Crean, chief science officer at percent of the adults surveyed last month in the United States, China and Mars, which strives to generate new scientific and technological insights to the United Kingdom said they believe COVID-19 will wind up adversely raise the bar on food safety. impacting the viability -- and, yes, safety -- of the global food supply chain many of us have come to expect. And almost as many (71 percent) think people’s access to food will consequently be negatively affected around the -(NewsUSA) world.